Cell MedX Corp CMXC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.05
- Day Range
- $0.05–0.05
- 52-Week Range
- $0.00–0.93
- Bid/Ask
- $0.02 / $0.05
- Market Cap
- $14.27 Mil
- Volume/Avg
- 30,520 / 16,432
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cell MedX Corp is an early stage development company focused on the discovery, development and, commercialization of therapeutic products for patients with diseases such as diabetes, by developing technologies to help manage the illness and related complications. The company's product portfolio consists of electromedical technologies, ebalance, and others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.cellmedx.com
Valuation
|
Metric
|
CMXC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CMXC
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.01 |
Interest Coverage | −3.73 |
Quick Ratio
CMXC
Profitability
|
Metric
|
CMXC
|
|---|---|
Return on Assets (Normalized) | −728.74% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CMXC
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Lpylpvm | Skqny | $182.7 Bil | |
SYK
| Stryker Corp | Thysnnkjg | Nfxy | $124.6 Bil | |
MDT
| Medtronic PLC | Bbqlrdb | Qvlvqbx | $105.2 Bil | |
BSX
| Boston Scientific Corp | Lcngggj | Lhkzfx | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Mkthnfck | Fghbd | $52.0 Bil | |
DXCM
| DexCom Inc | Zvdvcpqm | Hbsn | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Hkqmhcqxl | Zdty | $24.5 Bil | |
ALGN
| Align Technology Inc | Cdhjmghyn | Vhykg | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Dshhssnf | Jpbcjqb | $18.3 Bil | |
PODD
| Insulet Corp | Sddtlnmk | Nnkpk | $11.6 Bil |